BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Amniocentesis
,
Quercetin
,
rs2476601
,
NEUROG3
,
Apoptosis
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
suberoylanilide hydroxamic acid
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
DHRS2
H1F0
CLIC3
CFD
DACT3
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
heterocyclic compound binding
organic cyclic compound binding
organic cyclic compound metabolic process
heterocycle metabolic process
cellular aromatic compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Pancreatic cell lines treated with chromatin-targeting small molecules
Pre-cursor B cell acute lymphoblastic leukemia cells and patient samples treated with vorinostat
CD4-positive T cells from healthy donors treated with suberoylanilide hydroxamic acid
Foreskin fibroblast BJ cells tumorigenic or normal treated with vorinostat
Prostate cancer cells treated with Genistein and Vorinostat
Explore Curated Studies Results
Literature
Most Relevant Literature
Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat.
A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for …
Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparti…
The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy …
The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Loca…
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Sma…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ